Deciphera Pharmaceuticals, LLCWaltham, Massachusetts, United States
Disclosure information not submitted.
Paper 105 - EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES OF VIMSELTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE MOTION PHASE 3 TRIAL
Saturday, November 16, 20243:30 PM – 4:30 PM PST